BSEGodavari Drugs LtdMinimalNeutral
Announced Tue, 15 Jul · 16:54 IST

Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended 30.06.2025

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Godavari Drugs Ltd has submitted a compliance certificate under SEBI Regulation 74(5) for the quarter ended June 30, 2025. The certificate was issued by CIL Securities Limited, the company's Registrar and Share Transfer Agent (RTA), on July 14, 2025. CIL Securities confirmed that all securities received from Depository Participants for dematerialization during the quarter were properly confirmed to the depositories. The security certificates have been mutilated and cancelled, and the depositories' names have been substituted as registered owners in the Register of Members within the stipulated time.

Likely market impact

This is a routine quarterly regulatory compliance filing with no material impact on shareholders or the stock price. It simply confirms that the company's RTA is handling dematerialization requests properly as required by SEBI rules.